why choose us

First received: July 3, 2022

Clinical Trial: Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy

Study Status: Completed

Recruit Status: Completed

Condition: Acute Central Serous Retinopathy With Subretinal Fluid

Study Type: Interventional


Official Title: Subthreshold Micropulse 532 nm Green Laser Treatment of Acute Central Serous Chorioretinopathy: 18-month Results

Brief Summary: To evaluate the efficacy and safety of 532 nm green subthreshold micropulse laser (GSML) as a treatment for acute central serous chorioretinopathy (CSCR).

Read more